Michael Malynn
Senior Manager, Finance & Operations at Coherent Medicines
Boston, Massachusetts
Overview
Work Experience
Senior Manager, Finance & Operations
2023 - Current
Precision medicine-focused drug discovery using computation-enabled design to treat genetically defined disease drivers
Finance Manager
2021 - 2023
Gordian Ventures is a global life-sciences incubator that co-founds companies with insurmountable technological barriers to entry.
Senior Analyst, FP&A
2021 - 2021
Roivant Sciences is a biopharmaceutical company focused on the development of medicines and healthcare technologies to patients.
Raised $2,473,000,000.00 from Eventide, Fidelity, Viking Global Investors, RTW Investments, Patient Square Capital, Palantir Technologies, Dainippon Sumitomo Pharma, Suvretta Capital Management and SoftBank Capital.
Senior Associate, Finance
2019 - 2021
Financial Analyst
2018 - 2019
Economics/Econometrics Tutor
2017 - 2018
Finance Intern
2016 - 2016
SAGE Therapeutics develops and delivers novel medicines for most debilitating and disabling central nervous system disorders.
Raised $2,701,000,000.00 from Biogen.
Accounting Intern
2015 - 2015